| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.02B | 20.84B | 19.63B | 19.56B | 17.61B | 16.78B |
| Gross Profit | 9.09B | 9.43B | 8.49B | 7.68B | 7.20B | 6.52B |
| EBITDA | 7.23B | 8.37B | 6.98B | 6.23B | 5.29B | 4.70B |
| Net Income | 4.91B | 5.37B | 4.50B | 3.97B | 3.41B | 3.01B |
Balance Sheet | ||||||
| Total Assets | 50.76B | 63.24B | 49.72B | 41.67B | 35.45B | 34.76B |
| Cash, Cash Equivalents and Short-Term Investments | 2.08B | 3.18B | 2.51B | 3.48B | 3.77B | 2.49B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 8.60B | 12.72B | 9.40B | 7.61B | 6.14B | 6.27B |
| Stockholders Equity | 42.17B | 50.52B | 40.32B | 34.06B | 29.31B | 28.49B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.01B | 3.42B | 4.47B | 4.09B | 4.47B |
| Operating Cash Flow | 0.00 | 6.40B | 3.74B | 5.04B | 4.47B | 4.91B |
| Investing Cash Flow | 0.00 | -3.56B | -1.70B | -3.60B | -1.84B | -1.63B |
| Financing Cash Flow | 0.00 | -2.22B | -2.88B | -1.66B | -1.40B | -2.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥80.91B | 14.79 | ― | 3.34% | 2.61% | 16.80% | |
77 Outperform | ¥84.58B | 18.62 | 31.13% | 1.68% | 16.12% | 46.57% | |
66 Neutral | ¥94.68B | 16.82 | ― | 2.59% | 5.22% | -6.62% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥56.30B | -35.71 | ― | ― | 27.58% | -1.50% | |
55 Neutral | ¥128.29B | 144.60 | ― | ― | 31.57% | ― | |
49 Neutral | ¥177.02B | 112.18 | -19.16% | ― | 19.57% | -16.67% |